findmyKOL

Timothy McAlindon, MD, MPH

Enriched profile

Professor of Medicine; Program Director of Musculoskeletal Research, Division of Rheumatology, Allergy and Immunology · UMass Chan Medical School

ORCIDNPI
Region🇺🇸 Worcester, MA · Northeast · United StatesSpecialtyRheumatologyFocusOsteoarthritis Treatment and Mechanisms+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1997–2020

Timothy McAlindon is Professor of Medicine; Program Director of Musculoskeletal Research, Division of Rheumatology, Allergy and Immunology at UMass Chan Medical School. OpenAlex indexes 352 publications with 27,310 citations (h-index 66); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Timothy McAlindon, MD, MPH, is Professor of Medicine at UMass Chan Medical School. The public record shows 352 publications with 27,310 citations (h-index 66), centered on Osteoarthritis Treatment and Mechanisms, Total Knee Arthroplasty Outcomes, Rheumatoid Arthritis Research and Therapies. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 8 companies, 13 NIH-funded awards (1997–2020).

  • Most recent indexed publication: 2026 · The Journal of rheumatology
  • Top research focus: Osteoarthritis Treatment and Mechanisms
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 8 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Osteoarthritis4 trialsPain1 trialObesity1 trialOverweight1 trialRheumatoid Arthritis

Research focus

OpenAlex concept fingerprint
Osteoarthritis Treatment and MechanismsTotal Knee Arthroplasty OutcomesRheumatoid Arthritis Research and TherapiesKnee injuries and reconstruction techniquesLower Extremity Biomechanics and Pathologies

Drugs & molecules

across trials, industry payments and publications
Qutenzageneric · CapsaicinClinical trialsIndustry payments2Publications

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials1Industry payments1Averitas Pharma Inc.Clinical trialsIndustry payments5GRT US Holding, Inc.Clinical trialsIndustry payments5

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
352publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

27,310citations

Total citations across indexed works.

66h-index

Hirsch index (OpenAlex). i10-index 199.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
8companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
13NIH grants · 1997–2020

Federally funded research awards.

View funding

Public positions

sourced statements on record
  • Co-author

    OARSI (Osteoarthritis Research Society International) guidelines for non-surgical management of knee osteoarthritis

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tuftsmedicine.org

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    49.1%
    Corticosteroid49.1%
    Prednisone100%
    Part D15 patients
  • Cancer & immunology

    31.6%
    Folate Analog Metabolic Inhibitor31.6%
    Methotrexate100%
    Part D<11 patients
  • Musculoskeletal

    19.3%
    Nonsteroidal Anti-inflammatory Drug19.3%
    Diclofenac Sodium100%
    Part D<11 patients
Where care is delivered (Part B)64.3% facility · 35.7% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

13 NIH research awards on record, funded 19972020 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Jeffrey B. Driban162Charles B. Eaton111Grace H. Lo110

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/scientific-contributions/Timothy-E-McAlindon-38772310

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net
  • Doximity

    doximity.com/pub/timothy-mcalindon-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Other

    arthrometrics.com/team

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →arthrometrics.com
  • Other

    oarsi.org/timothy-mcalindon

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oarsi.org
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Southampton Faculty of Medicine

    1982
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • MPH

    Boston University School of Public Health

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com
  • Board Certified

    Internal Medicine, American Board of Internal Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com

Editorial & leadership roles

journal and society appointments
  • Editorialist/contributor

    Arthritis & Rheumatology (Wiley), authored 'Toward a New Paradigm of Knee Osteoarthritis' editorial

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acrjournals.onlinelibrary.wiley.com
  • Investigator/collaborator

    Osteoarthritis Initiative (OAI), external consultant listing at UMass Chan PHARE

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →umassmed.edu

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.